JP2022537350A5 - - Google Patents

Info

Publication number
JP2022537350A5
JP2022537350A5 JP2021575327A JP2021575327A JP2022537350A5 JP 2022537350 A5 JP2022537350 A5 JP 2022537350A5 JP 2021575327 A JP2021575327 A JP 2021575327A JP 2021575327 A JP2021575327 A JP 2021575327A JP 2022537350 A5 JP2022537350 A5 JP 2022537350A5
Authority
JP
Japan
Prior art keywords
halogen
hydrogen
formula
haloalkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021575327A
Other languages
English (en)
Japanese (ja)
Other versions
JP7494224B2 (ja
JP2022537350A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037881 external-priority patent/WO2020257161A1/en
Publication of JP2022537350A publication Critical patent/JP2022537350A/ja
Publication of JP2022537350A5 publication Critical patent/JP2022537350A5/ja
Application granted granted Critical
Publication of JP7494224B2 publication Critical patent/JP7494224B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021575327A 2019-06-18 2020-06-16 ビアリールジアルキルホスフィンオキシドｆｐｒ２アゴニスト Active JP7494224B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962862897P 2019-06-18 2019-06-18
US62/862,897 2019-06-18
PCT/US2020/037881 WO2020257161A1 (en) 2019-06-18 2020-06-16 Biaryl dialkyl phosphine oxide fpr2 agonists

Publications (3)

Publication Number Publication Date
JP2022537350A JP2022537350A (ja) 2022-08-25
JP2022537350A5 true JP2022537350A5 (cg-RX-API-DMAC7.html) 2023-06-21
JP7494224B2 JP7494224B2 (ja) 2024-06-03

Family

ID=71409568

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021575327A Active JP7494224B2 (ja) 2019-06-18 2020-06-16 ビアリールジアルキルホスフィンオキシドｆｐｒ２アゴニスト

Country Status (7)

Country Link
US (1) US20220298186A1 (cg-RX-API-DMAC7.html)
EP (1) EP3986903B1 (cg-RX-API-DMAC7.html)
JP (1) JP7494224B2 (cg-RX-API-DMAC7.html)
KR (1) KR102953013B1 (cg-RX-API-DMAC7.html)
CN (1) CN114008059B (cg-RX-API-DMAC7.html)
ES (1) ES2946673T3 (cg-RX-API-DMAC7.html)
WO (1) WO2020257161A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102623473B1 (ko) * 2017-06-09 2024-01-09 브리스톨-마이어스 스큅 컴퍼니 피페리디논 포르밀 펩티드 2 수용체 및 포르밀 펩티드 1 수용체 효능제
CN113166134B (zh) 2018-11-26 2024-06-14 百时美施贵宝公司 作为甲酰肽2受体激动剂的吡咯烷酮衍生物
JP7802765B2 (ja) 2020-08-12 2026-01-20 ブリストル－マイヤーズ スクイブ カンパニー オキソピロリジン尿素ｆｐｒ２アゴニスト

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10302500A1 (de) 2003-01-23 2004-07-29 Merck Patent Gmbh Carbonsäureamidderivate
EP3414227B1 (en) 2015-12-10 2021-11-24 Bristol-Myers Squibb Company Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
KR102623473B1 (ko) * 2017-06-09 2024-01-09 브리스톨-마이어스 스큅 컴퍼니 피페리디논 포르밀 펩티드 2 수용체 및 포르밀 펩티드 1 수용체 효능제
US10676431B2 (en) * 2018-03-05 2020-06-09 Bristol-Myers Squibb Company Phenylpyrrolidinone formyl peptide 2 receptor agonists

Similar Documents

Publication Publication Date Title
JP2021516240A5 (cg-RX-API-DMAC7.html)
JP2022537350A5 (cg-RX-API-DMAC7.html)
ES2242351T3 (es) Derivados de imidazol sustituidos y su uso como inhibidores de citoquina.
JP2024050527A5 (cg-RX-API-DMAC7.html)
HRP20220118T1 (hr) Agonisti fenilpirolidinon formil peptidnih 2 receptora
EP0640599B1 (en) 4-Aminopyrimidine derivatives
JP2013545791A5 (cg-RX-API-DMAC7.html)
RU2342383C2 (ru) ПРОИЗВОДНЫЕ ИМИДАЗОЛ-4-ИЛЭТИНИЛПИРИДИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ) И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНКСИОЛИТИКА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ НАРУШЕНИЙ, ОПОСРЕДУЕМЫХ РЕЦЕПТОРОМ mGLuR5
JP2022530049A5 (cg-RX-API-DMAC7.html)
JP2019131544A5 (cg-RX-API-DMAC7.html)
JP2023544476A5 (cg-RX-API-DMAC7.html)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2005533827A5 (cg-RX-API-DMAC7.html)
JP2017504640A5 (cg-RX-API-DMAC7.html)
JP2005519024A5 (cg-RX-API-DMAC7.html)
RU2010101212A (ru) Бром-фенил замещенные тиазолилдигидропиримидины
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
RU2008119651A (ru) Производные дикарбоновых кислот и их применение
JP2021535174A5 (cg-RX-API-DMAC7.html)
JP2019532072A5 (cg-RX-API-DMAC7.html)
JP2013531070A5 (cg-RX-API-DMAC7.html)
JP2006507355A5 (cg-RX-API-DMAC7.html)
JPWO2023195529A5 (cg-RX-API-DMAC7.html)
JP2023506899A5 (cg-RX-API-DMAC7.html)
JP2020111571A5 (cg-RX-API-DMAC7.html)